Alendronate is a bisphosphonate that binds to bone hydroxyapatite and specifically inhibits the activity of osteoclasts, the bone-resorbing cells.Intravenous ranitidine was revealed to double the bioavailability of oral alendronate. The scientific importance of the elevated bioavailability and whether equivalent boosts will come about in clients of